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Summary
Objective: To determine the frequency and clinical characteristics of osteoarticular complica-
tions of brucellosis in an endemic region in Iran.
Methods: In a prospective study we evaluated 245 patients with brucellosis diagnosed between
January 2004 and December 2005. Patients included were those older than 8 years of age and who
had clinical features suggestive of brucellosis and specific antibodies at significant titers, and/or
positive blood or body fluid culture for Brucella species. A bone scan was performed in those with
a clinical suspicion of osteoarticular involvement.
Results: Seventy patients (28.6%) had osteoarticular complications. Sacroiliitis was the most
common complication (75.7%), followed by spondylitis (21.4%) and peripheral arthritis (8.6%).
Spondylitis was the most common osteoarticular complication in the elderly. Relapses occurred in
five (2%) patients, three of them with spondylitis.
Conclusions: Osteoarticular disease is the most common complication of brucellosis in Western
Iran. Sacroiliitis is themost common form of osteoarticular complication. With the use of a proper
treatment regimen, the prospect for recovery is good.
# 2007 International Society for Infectious Diseases. Published by Elsevier Ltd. All rights
reserved.Introduction
Brucellosis is a major zoonosis with a worldwide distribution
and represents a serious public health problem in many
developing countries.1 In Iran the incidence of brucellosis* Corresponding author. Tel.: +98 918 1113258;
fax: +98 811 8269808.
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doi:10.1016/j.ijid.2007.01.008has increased in recent years due to the impossibility of
completely eradicating it in animals, especially sheep and
goats. The highest incidence rate in Iran, 130 per 100 000
population, has been reported from Hamedan province in the
western part of the country.2
The clinical manifestations of brucellosis are diverse and
non-specific such as fever, malaise, sweating, hepatomegaly
or splenomegaly; however, it may result in complications
involvingmultiple organs andmost of all themusculoskeletalPublished by Elsevier Ltd. All rights reserved.
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discrepancies regarding the frequency of osteoarticular
complications and their particular sites of involvement.3—
8 The aim of this study was to determine the frequency and
characteristics of osteoarticular brucellosis in an endemic
region in Iran.
Methods
Study population
Two hundred and forty-five patients older than 8 years of age
with active brucellosis diagnosed between January 2004 and
December 2005 at the Infectious Diseases Unit of Sina Hospi-
tal were included in the study and prospectively monitored in
order to discover the osteoarticular form of the disease
during its initial phase.
Sina Hospital is the only referral center for infectious
diseases in Hamedan province in the west of Iran, which
serves a population of about 1 500 000 people, consisting of
both rural (50%) and urban populations.
Diagnosis of brucellosis
Diagnosis was established in all patients with a clinical
picture of brucellosis, by one of the following criteria: (1)
isolation of Brucella spp in blood or other fluids or bone
marrow culture; (2) a clinical presentation compatible with
brucellosis in the presence of significant titers of specific
antibodies (standard tube agglutination test 1/160 or
Coombs test for Brucella 1/160).
Data collection
Demographic, clinical, and laboratory data for all patients,
including complete blood count, erythrocyte sedimentationTable 1 Demographic and clinical characteristics of 245 patient
Variable Patients with osteoarticular
complications N = 70 (28.6%)
Age (mean years  SD) 35.47  20.23
Gender, female/male 31/39
Living, rural 52 (74.3)
Fever 52 (74.3)
Chills 45 (64.3)
Headache 45 (64.3)
Arthralgia 58 (82.9)
Myalgia 45 (64.3)
Sweating 55 (78.6)
Anorexia 47 (67.1)
Weight loss 29 (41.4)
Low back pain 58 (82.9)
Cough 9 (12.9)
Vomiting 8 (11.4)
Abdominal pain 11 (15.7)
Splenomegaly 9 (12.9)
Hepatomegaly 4 (5.7)
Orchitis 1 (1.4)
Meningismus 0
NS: not significant. Figures are n (%).rate (ESR), C-reactive protein (CRP), serum electrolytes,
creatinine, liver enzymes and urinalysis were recorded.
A radionuclide bone scan with technetium-99 methylene
diphosphate was performed when there was a strong clinical
suspicion of osteoarticular involvement. Increased uptake in
an affected site was considered to be positive.
Osteoarticular complication was defined as pain and two
or more inflammatory signs in any peripheral joint (heat,
redness, swelling, definite restriction of movement) or
inflammatory pain (pain unrelieved with rest) together with
radionuclide uptake in an osteoarticular location.
Statistical analysis
Data were analyzed using SPSS statistical package, version
10. Student’s t-test was used to compare the mean values of
quantitative variables. Comparison of values of qualitative
variables was carried out by Chi-square test. A p-value of
<0.05 was considered significant.
Results
During the two-year period 2004—2005, 245 consecutive
patients with brucellosis (152 males, 93 females) were
enrolled in this study. The mean age of patients was
26.9  19.2 years (range 8—82 years). One hundred and
ninety (77.6%) of them were from rural areas and 55
(22.4%) were from urban areas. All patients had high occupa-
tional risk factors for brucellosis, as they were either live-
stock farmers or shepherds from rural regions, or had a
history of consuming unpasteurized milk and/or cheese made
from it. The predominant clinical manifestations observed in
patients were arthralgia (78.4%) and fever (76.7%). Seventy
(28.6%) patients had osteoarticular involvement.
The demographic and clinical characteristics of patients
with and without osteoarticular manifestations are shown ins with brucellosis
Patients without osteoarticular
complications N = 175 (71.4%)
p Value
37.56  18.8 NS
62/113 NS
138 (78.9) NS
136 (77.7) NS
53 (30.3) <0.001
92 (52.6) NS
134 (76.6) NS
123 (70.3) NS
113 (64.6) NS
103 (58.9) NS
80 (45.7) NS
104 (59.4) <0.001
6 (3.4) 0.009
12 (6.9) NS
22 (12.9) NS
5 (2.9) 0.002
0 0.001
14 (8) 0.04
1 (0.6) NS
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Table 2 Laboratory and serologic data of 245 patients with brucellosis
Laboratory findings Patients with osteoarticular
complications N = 70 (28.6%)
Patients without osteoarticular
complications N = 175 (71.4%)
p Value
Hb <12 g/dl 3/58 (5.2) 24/146 (16.4) 0.029
WBC cells/mm3
<4000 1/57 (1.8) 3/141 (2.1) NS
4000—10 000 50/57 (87.7) 112/141 (79.4) NS
>10 000 6/57 (10.5) 26/141 (18.4) NS
Lymphocytes >40% 22/49 (44.9) 16/48 (33.3) NS
ESR >30 mm/h 21/53 (39.6) 17/49 (34.7) NS
SGOT >40 15/39 (38.5) 15/34 (44.1) NS
SGPT >40 14/39 (35.9) 12/32 (37.5) NS
Wright titer
1:160 32 (45.7) 51 (29.1) NS
1:320—1:640 31 (44.3) 102 (58.3) NS
>1:640 7 (10) 22 (12.6) NS
NS: not significant. Figures are n (%). WBC, white blood cell count; ESR, erythrocyte sedimentation rate.Table 1. No differences were observed in the demographic
characteristics of patients with and without osteoarticular
involvement. Patients with osteoarticular complications had
a significantly higher frequency of coughs, chills, splenome-
galy and hepatomegaly, but a lower frequency of orchitis
compared with those without osteoarticular complications.
There were no significant laboratory and serologic differ-
ences between the groups with and without osteoarticular
brucellosis during the initial examination, except for a higher
rate of anemia in patients without osteoarticular involve-
ment (Table 2). A radionuclide bone scan was performed in 80
patients and was positive in 70 (87.5%) of them.
Among the osteoarticular complications, sacroiliitis was
the most common (75.7%), followed by spondylitis and per-
ipheral arthritis (Table 3). Four patients had spondylitis plus
sacroiliitis. Sacroiliitis was unilateral in 31 patients (58.5%),
predominantly in females, and bilateral in 22 patients
(41.5%), predominantly in males. Spondylitis was the most
common osteoarticular involvement observed in the elderly
(60 years), but the secondmost common in other age groups
(Table 4). The lumbar spine was affected in 12 patients, andTable 3 Sites of involvement in 70 patients with osteoarti-
cular brucellosis; four patients had sacroiliitis plus spondylitis
Sex Total (%)
Male
n (%)
Female
n (%)
Sacroiliitis 32 (45.7) 21 (30) 53 (75.7)
Unilateral 15 16 31
Bilateral 17 5 22
Spondylitis 8 (11.4) 7 (10) 15 (21.4)
Peripheral arthritis 2 (2.9) 4 (5.7) 6 (8.6)
Knee 1 2 3
Wrist 1 0 1
Shoulder 0 1 1
Metacarpophalangeal 0 1 1the thoracic spine in three patients. Peripheral arthritis was
found in six (8.6%) patients, four of whom (66.7%) were over
60 years of age.
Therapy consisted of doxycycline (100 mg every 12 h p.o.)
plus rifampin (600 mg/day p.o.) for 45 days. Patients with
osteoarticular manifestations were treated with doxycycline
for 45 days plus streptomycin (1 g/day i.m.) for the first 21
days. In patients with spondylitis, therapy with doxycycline
was continued for three months. Patients were successfully
cured with one of the treatment regimens, and relapses were
only found in five patients (three with spondylitis, one with
sacroiliitis, and one without osteoarticular involvement)
after a six-month follow-up (2% relapse rate); they received
a new course of the same treatment they had had previously.
Discussion
Brucellosis is a public health problem in many developing
countries, including Iran. In these regions brucellosis has
primarily been caused by Brucella melitensis, which is the
most virulent species, and causes the severest acute forms of
brucellosis with disabling complications.9,10
Osteoarticular disease is themost common complication of
brucellosis. According to different studies the frequency of
this complication varies from 10% to 80% depending on the
series, the age of the patients, and the infecting Brucella
species.3,4,7,8,11—16 Still, in the majority of reports it ranges
from 20% to 40%.4,7,12,15 In our region the frequency rate is
28.5%, which is the mean rate among those mentioned in the
literature.7,12 Inour study, ageand sexdistributionsofpatients
with or without osteoarticular complications were similar to
those mentioned in other studies.8,12,14 Worldwide, males are
affected more often than females, with a ratio of 5:2—5:3 in
endemic areas. Also, in multiple large series, individuals in
their third or fifth decades of life have been found to be most
commonly affected.17 Osteoarticular complications have
sometimesbeen linked toageneticpredisposition,with recent
data suggesting an association with HLA-B39.18
Peripheral arthritis has been reported to be the most
common form of osteoarticular involvement in the countries
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Table 4 Types of osteoarticular involvement in 70 patients with brucellosis according to age groups
Age groups Sacroiliitis n (%) Spondylitis n (%) Peripheral arthritis n (%) Total n (%)
8—19 21 (30) 4 (5.7) 0 25 (35.7)
20—39 18 (25.7) 4 (5.7) 1 (1.4) 23 (32.9)
40—59 10 (14.3) 2 (2.9) 1 (1.4) 13 (18.6)
60 4 (5.7) 5 (7.1) 4 (5.7) 13 (18.6)of South America and the Middle East.5,8,12,19,20 However, as
in our series, sacroiliitis has accounted for the majority of
cases of osteoarticular complications in two large series from
the Middle East and in other parts of the world.13,21
Sacroiliitis is mainly unilateral in more than two thirds of
patients;8,10,12,14 we found unilateral sacroiliitis in 58.5% of
our patients. However, Tasova et al.6 and Cordero-Sanchez
et al.22 have found a high rate of bilateral sacroiliitis (47% and
60%, respectively).
The reported prevalence of brucella spondylitis varies
significantly, ranging from 6% to 65%, and usually occurs in
older patients.3,8,14,23 The lumbar spine is more frequently
involved.20,24 In our study, spondylitis was the second major
osteoarticular complication of brucellosis (21.4%), while
being the most common form in patients older than 60 years
of age.
Differences in distribution patterns of osteoarticular bru-
cellosis may be related to the characteristics of the examined
population, stages of the disease, diversity of applied criteria
for defining the cases, and diagnostic procedures undergone,
as well as the presence of sufficient prospective studies. We
believe that a considerable number of patients with brucella
arthritis who had first been referred to rheumatologists and
orthopedists may have suffered longer diagnostic delays or
even misdiagnoses, and thus not been referred to our hospi-
tal, which may account for the lower prevalence of periph-
eral arthritis in our study. On the other hand, we have been
able to show the true incidence of sacroiliitis and spondylitis
by means of radionuclide bone scans, because in contrast to
standard X-rays that are usually normal early in the course of
the disease, a radionuclide bone scan is the most sensitive
technique for early detection of acute sacroiliitis and other
skeletal abnormalities.17
A variety of antimicrobial combinations have been used
for the treatment of osteoarticular complications. However,
the regimen of doxycycline (200 mg/day p.o.) for six weeks
plus streptomycin (1 g/day i.m.) for three weeks is the most
effective therapy.1,25 Since patients with spinal involvement
have high rates of relapse and failure compared to other
types of osteoarticular complications, most authorities
recommend the use of doxycycline for at least 12 weeks
for treatment of brucella spondylitis.23,26,27 The lowest
relapse rate in our series could be due to the use of the
doxycycline plus streptomycin regimen for patients with
osteoarticular complications and prolonged treatment for
spondylitis.
In conclusion, brucellosis is one of the most common
causes of osteoarticular diseases in endemic areas of Western
Iran. Themost common forms of osteoarticular complications
are sacroiliitis and spondylitis. Proper diagnosis and treat-
ment of these involvements will significantly reduce the
failure and relapse rates.Conflict of interest: No conflict of interest to declare.
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